Immunohistochemistry (IHC) screening in 1043 various solid tumours showed TRKA expression in 1.6% of samples, including CRC, lung cancer, biliary tract carcinoma and thyroid cancer. This evidence concerns the gene NTRK1 and colorectal carcinoma.